Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
TAC1 (for transcriptional activator of CDR genes) is critical for the upregulation of the ABC transporters CDR1 and CDR2, which mediate azole resistance in Candida albicans. While a wild-type TAC1 allele drives high expression of CDR1/2 in response to inducers, we showed previously that TAC1 can be hyperactive by a gain-of-function (GOF) point mutation responsible for constitutive high expression of CDR1/2. High azole resistance levels are achieved when C. albicans carries hyperactive alleles only as a consequence of loss of heterozygosity (LOH) at the TAC1 locus on chromosome 5 (Chr 5), which is linked to the mating-type-like (MTL) locus. Both are located on the Chr 5 left arm along with ERG11 (target of azoles). In this work, five groups of related isolates containing azole-susceptible and -resistant strains were analyzed for the TAC1 and ERG11 alleles and for Chr 5 alterations. While recovered ERG11 alleles contained known mutations, 17 new TAC1 alleles were isolated, including 7 hyperactive alleles with five separate new GOF mutations. Single-nucleotide-polymorphism analysis of Chr 5 revealed that azole-resistant strains acquired TAC1 hyperactive alleles and, in most cases, ERG11 mutant alleles by LOH events not systematically including the MTL locus. TAC1 LOH resulted from mitotic recombination of the left arm of Chr 5, gene conversion within the TAC1 locus, or the loss and reduplication of the entire Chr 5. In one case, two independent TAC1 hyperactive alleles were acquired. Comparative genome hybridization and karyotype analysis revealed the presence of isochromosome 5L [i(5L)] in two azole-resistant strains. i(5L) leads to increased copy numbers of azole resistance genes present on the left arm of Chr 5, among them TAC1 and ERG11. Our work shows that azole resistance was due not only to the presence of specific mutations in azole resistance genes (at least ERG11 and TAC1) but also to their increase in copy number by LOH and to the addition of extra Chr 5 copies. With the combination of these different modifications, sophisticated genotypes were obtained. The development of azole resistance in C. albicans is therefore a powerful instrument for generating genetic diversity.
Coste
Alix
A
Institute of Microbiology, University of Lausanne and University Hospital Center, Rue du Bugnon 48, CH-1011, Lausanne, Switzerland.
Selmecki
Anna
A
Forche
Anja
A
Diogo
Dorothée
D
Bougnoux
Marie-Elisabeth
ME
d'Enfert
Christophe
C
Berman
Judith
J
Sanglard
Dominique
D
D000483:Alleles; D000782:Aneuploidy; D001393:Azoles / Q000494:pharmacology*; D002176:Candida albicans / Q000166:cytology / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification*; D002874:Chromosome Mapping; D015825:Chromosomes, Fungal; D025141:Drug Resistance, Fungal / Q000187:drug effects*; D019143:Evolution, Molecular; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism; D005785:Gene Conversion / Q000187:drug effects; D018628:Gene Dosage; D020440:Gene Duplication / Q000187:drug effects; D005838:Genotype; D008826:Microbial Sensitivity Tests; D008938:Mitosis / Q000187:drug effects; D009154:Mutation / Q000235:genetics; D009693:Nucleic Acid Hybridization; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011995:Recombination, Genetic / Q000187:drug effects
D001393:Azoles; D005656:Fungal Proteins
Genetics. 2006 Apr;172(4):2139-56
16452151
Microbiology. 1999 Oct;145 ( Pt 10):2701-13
10537192
Curr Opin Microbiol. 2002 Aug;5(4):379-85
12160856
Genetics. 2006 Dec;174(4):1737-44
17028326
Mol Cell Biol. 2001 Oct;21(19):6395-405
11533229
Curr Genet. 2004 Jun;45(6):390-8
15034753
Mol Gen Genet. 1997 Oct;256(4):397-405
9393437
Eukaryot Cell. 2007 Feb;6(2):291-301
17158732
J Bacteriol. 2000 Mar;182(6):1515-22
10692355
Clin Microbiol Rev. 1998 Apr;11(2):382-402
9564569
Science. 2006 Jul 21;313(5785):367-70
16857942
Curr Infect Dis Rep. 2006 Nov;8(6):449-56
17064638
Med Mycol. 2005 Jun;43(4):285-318
16110776
Gene. 1997 Jan 15;184(2):229-35
9031633
Oral Dis. 1997 May;3 Suppl 1:S102-9
9456667
Antimicrob Agents Chemother. 2000 Jan;44(1):63-7
10602724
Fungal Genet Biol. 2005 Aug;42(8):676-83
15946869
J Bacteriol. 1990 Mar;172(3):1276-83
2407719
Mol Genet Genomics. 2002 Mar;267(1):96-106
11919720
J Biol Chem. 1997 Feb 28;272(9):5682-8
9038178
Antimicrob Agents Chemother. 2002 Jun;46(6):1695-703
12019078
Eukaryot Cell. 2004 Dec;3(6):1391-7
15590814
Antimicrob Agents Chemother. 2005 May;49(5):1745-52
15855491
Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7
9210670
Antimicrob Agents Chemother. 2004 Apr;48(4):1136-44
15047513
Antimicrob Agents Chemother. 1997 Jul;41(7):1488-94
9210671
Infect Immun. 2005 Dec;73(12):8069-78
16299301
Mol Microbiol. 2002 Mar;43(5):1197-214
11918807
Mol Microbiol. 2006 Mar;59(5):1452-72
16468988
Eukaryot Cell. 2007 Jun;6(6):1041-52
17416899
Antimicrob Agents Chemother. 2000 Oct;44(10):2693-700
10991846
Antimicrob Agents Chemother. 1998 Dec;42(12):3065-72
9835492
Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84
11557454
Yeast. 2005 Jan 15;22(1):57-70
15635674
Antimicrob Agents Chemother. 1998 Feb;42(2):241-53
9527767
Biochem Biophys Res Commun. 1999 Aug 19;262(1):174-9
10448088
Genetics. 1993 Jul;134(3):717-28
8349105
Mol Microbiol. 2005 Mar;55(5):1553-65
15720560
Mol Microbiol. 2004 Jun;52(5):1451-62
15165246
Mol Gen Genet. 1997 Oct;256(4):406-15
9393438
FEMS Microbiol Lett. 1999 Nov 15;180(2):171-5
10556708
Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86
8585712
Microbiology. 2002 Apr;148(Pt 4):1061-72
11932451
Diagn Microbiol Infect Dis. 2004 Sep;50(1):25-32
15380275
Antimicrob Agents Chemother. 2003 Apr;47(4):1207-12
12654648
Genetics. 2003 May;164(1):31-46
12750319
Antimicrob Agents Chemother. 1996 Dec;40(12):2835-41
9124851
Mol Cell Biol. 2005 Aug;25(16):7226-38
16055731
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5150-5
9560244
Mol Microbiol. 2004 Aug;53(4):1177-94
15306020
Fungal Genet Biol. 2007 Aug;44(8):789-98
17300968
Curr Genet. 2000 Dec;38(5):248-55
11191208
Eukaryot Cell. 2004 Dec;3(6):1639-52
15590837
J Biosci Bioeng. 2002;93(2):221-7
16233191
Eukaryot Cell. 2005 Jan;4(1):156-65
15643071
Antimicrob Agents Chemother. 2004 Dec;48(12):4505-12
15561818
Lancet Infect Dis. 2002 Feb;2(2):73-85
11901654